TSE:4523Pharmaceuticals
Eisai (TSE:4523) Posts First Quarter Growth, Is The Stock Fully Priced?
Eisai (TSE:4523) recently reported first quarter earnings, with sales of ¥234,330 million, net income of ¥18,242 million, and basic earnings per share of ¥64.71 from continuing operations, drawing fresh attention to the stock.
See our latest analysis for Eisai.
Eisai's recent first quarter update has coincided with a strong 30-day share price return of 15.20% and a 1-year total shareholder return of 16.14%. However, total shareholder returns over three and five years are still lower, which...